The Milwaukee health information technology company announced plans to sell up to 9 million shares for $3 each, sending its stock price plummeting.
[Read more of this report]Its the second acquisition in as many months. In June, Merge announced its plans to acquire the North Carolina clinical trials software company etrials Worldwide, which completed in mid-July. Less than two weeks ago Merge reported second-quarter results in which it eked out a net income of $400,000 — an improvement over the $18.2 million loss over the same period last year. The company called the results — in particular its operating income of $4.1 million — the best results in three years.
[Read more of this report]